Safety Study of PP-007 in Subjects With Acute Ischemic Stroke
Clinical trial NCT04677777 · COMPLETED
Trial details
- NCT number
- NCT04677777
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-24
- Primary completion
- 2025-02-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.